Pfizer and the first candidate for the BioNTech vaccine

We now have a large amount of data preprint on Pfizer’s (NYSE: PFE) / BioNTech (NASDAQ: BNTX) first effort coronavirus vaccine candidate. This is actually the first real set of data on any of the gene vaccines, as Moderna’s (NASDAQ: MRNA) document on its Phase I trial has yet to …

Read More »